» Articles » PMID: 32729089

New Frontiers for Site-Directed RNA Editing: Harnessing Endogenous ADARs

Overview
Specialty Molecular Biology
Date 2020 Jul 31
PMID 32729089
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

RNA editing activity can be exploited for the restoration of disease-causing nonsense and missense mutations and as a tool to manipulate the transcriptome in a simple and programmable way. The general concept is called site-directed RNA editing and has high potential for translation into the clinics. Due to its different mode of action RNA editing may well complement gene editing and other gene therapy options. In this method chapter, we particularly highlight RNA editing strategies that harness endogenous ADARs. Such strategies circumvent the delivery and expression of engineered editases and are notably precise and simple. This is particularly true if endogenous ADARs are recruited with chemically modified antisense oligonucleotides, an approach we call RESTORE (recruiting endogenous ADAR to specific transcripts for oligonucleotide-mediated RNA editing). To foster the research and development of RESTORE we now report a detailed protocol for the procedure of editing reactions, and a protocol for the generation of partly chemically modified RESTORE ASOs with a combination of in vitro transcription and ligation.

Citing Articles

Structural perspectives on adenosine to inosine RNA editing by ADARs.

Fisher A, Beal P Mol Ther Nucleic Acids. 2024; 35(3):102284.

PMID: 39165563 PMC: 11334849. DOI: 10.1016/j.omtn.2024.102284.


Genetic and Clinical Analyses of the -c.226C>T Variant Resulting in a Dual Mutational Mechanism.

Sundaresan Y, Rivera A, Obolensky A, Gopalakrishnan P, Ohayon Hadad H, Shemesh A Genes (Basel). 2024; 15(6).

PMID: 38927740 PMC: 11202946. DOI: 10.3390/genes15060804.


A pipeline for identifying guide RNA sequences that promote RNA editing of nonsense mutations that cause inherited retinal diseases.

Schneider N, Steinberg R, Ben-David A, Valensi J, David-Kadoch G, Rosenwasser Z Mol Ther Nucleic Acids. 2024; 35(1):102130.

PMID: 38375504 PMC: 10875612. DOI: 10.1016/j.omtn.2024.102130.


Development of a selection assay for small guide RNAs that drive efficient site-directed RNA editing.

Diaz Quiroz J, Ojha N, Shayhidin E, De Silva D, Dabney J, Lancaster A Nucleic Acids Res. 2023; 51(7):e41.

PMID: 36840708 PMC: 10123091. DOI: 10.1093/nar/gkad098.


Site-directed A → I RNA editing as a therapeutic tool: moving beyond genetic mutations.

Diaz Quiroz J, Siskel L, Rosenthal J RNA. 2023; 29(4):498-505.

PMID: 36669890 PMC: 10019371. DOI: 10.1261/rna.079518.122.